Patent Application
20060045897
There are no previously filed, nor currently any co-pending applications, anywhere in the world.
1. Field of the Invention
The present invention relates generally to wart treatment, and more particularly, to occlusive articles for wart therapy.
2. Description of the Related Art
A wide variety of warts are found on human skin and are caused by the human papilloma virus (HPV). The following types of warts are caused by HPV: Verruca vulgaris (the common wart); plantar warts, mosaic warts, planar warts, plantar warts, palmar warts, and condyloma accuminatum (venereal warts).
As obdurate and unsightly as its name, Verruca vulgaris inconveniently finds temporary niches on thousands of people, many of whom avoid revealing its unwelcome presence. It wreaks havoc in the cracks and crevasses of skin, most often causing cosmetic embarrassment and pain.
Throughout the years a number of therapies have been developed for treating warts such as surgical excision, laser vaporization, topical chemical treatment, and cryotherapy (blister-producing method applying liquid nitrogen). Cryotherapy, independent or in conjunction with a secondary methodology, has evolved as the professional treatment of choice for most practicing clinicians. However, freezing warts with liquid nitrogen results in severe pain and discomfort and is frightening to children and young teens.
Adhesive tape has been a non-FDA approved, home remedy for warts for years. This methodology was historical spurned by the professional clinical community. However, recent studies have been published that objectively investigated the efficacy of occlusive therapy for warts using common industrial duct tape. The study produced dramatic results. Resolution of the wart occurred in 22/26 (85%) of patients in the duct tape arm vs. 15/25 (60%) in the cryotherapy arm (p=0.5) within the follow up period of 2 months. Accordingly many dermatologist and family physicians have now added occlusive therapy to their therapeutic regimens.
While the efficacy of occlusive therapy has received strong acceptance in the professional and patient communities, there remain many negative attributes from the perspective of the end user. First, the cosmetic appeal of many tapes is socially distracting. Especially for peer conscious teens, occlusive articles in the form of common duct, or otherwise industrial, tape tends to draw the scrutiny and often harassment of classmates. Aside from cosmetics, the industrial tape is cut to size and shape by the user. This is hardly a reproducible process and often attenuates the adhesion of the industrial tape by inadvertent contact with skin oils and particulate debris. Strong adhesion is critical for efficacy as the tape must stay on for approximately 5-7 days. Another disadvantage is the lack of commercially available pre-cut shapes that conform to common body parts and appendages that are common wart sites such as fingers, knuckles, crevices, toes and heels. Furthermore, and in conjunction with pre-cut shapes, the availability of occlusive adhesive articles with a corresponding release liner to ease preparation while limiting contact with skin oils and particulate debris would be very advantageous to the practical use of occlusive therapy.
Accordingly, there is not only a need for a less painful and less invasive therapy for wart removal, but also a more cosmetically acceptable, user friendly solution in a manner which is quick, easy, and effective. The development of the occlusive articles for wart treatment fulfills this need.
A search of the prior art did not disclose any patents that read directly on the claims of the instant invention; however, the following references were considered related.
The following patents disclose various methods, devices, and systems for wart treatment and related disorders:
U.S. Pat. No. 5,641,507, issued in the name of Devillez;
U.S. Pat. No. 6,593,371 B1, issued in the name of Staggs;
U.S. Pat. No. 5,702,694, issued in the name of Chamness;
U.S. Pat. No. 6,355,251 B1, issued in the name of Zamoyski;
U.S. Pat. No. 6,403,123 B1, issued in the name of Scott et al.;
U.S. Pat. No. 6,020,005, issued in the name of Weathers;
U.S. Pat. No. 6,384,295 B2, issued in the name of Wehde; and
U.S. Pat. No. 5,476,664, issued in the name of Robinson et al.
U.S. Pat. No. 5,310,402, issued in the name of Rollband discloses a tape for attaching bandages, with non-adhesive tabs at each end for easy manipulation and removal while wearing gloves.
U.S. Pat. No. 5,637,080, issued in the name of Geng discloses an external wound dressing having a reversibly movable cover.
U.S. Pat. No. 6,214,915 B1, issued in the name of Avakian et al. discloses stabilized thermoplastic compositions.
Web Site Publication, Duct Tape of Benefit in the Treatment of Verruca Vulgaris, University of Mich. Department of Pediatrics, December 2002.
Consequently, a need has been identified for a less painful and invasive therapy for wart removal that is convenient and specifically designed for the application of occlusive therapy.
Therefore, it is an object of the present invention to provide an occlusive article for wart treatment in a pre-cut shape and size to assist application and conformation to anatomical body parts and appendages that commonly harbor warts with or without an adhesive coating to fix the occlusive article in position.
It is another object of the present invention to provide an occlusive article for wart therapy in cosmetic tints and shades that mimic skin tones and minimize the visual detection of therapy by casual observers.
It is another object of the present invention to provide a release liner for occlusive articles with adhesives to aid in the physical application and minimize contamination of the adhesive with inadvertent skin oil and debris contact.
It is another object of the present invention to provide a method for die cutting the occlusive articles and release liners together and packaging them as independent units.
It is another object of the present invention to provide an assortment of shapes and sizes to make selection of the appropriate shape and size optional to the end user.
It is another object of the present invention to provide occlusive articles for wart therapy in a continuous roll.
It is another object of the present invention to provide a dispenser for the occlusive articles in a continuous roll.
It is another object of the present invention to provide occlusive articles for wart therapy as a part of a kit with other synergistic therapies.
It is another object of the present invention to provide occlusive articles with a secondary adhesive backing to augment the occlusion and fixation of the occlusive article to the treatement area.
Briefly described according to one embodiment of the present invention, an occlusive article for wart treatment is disclosed, comprised of an occlusive component adapted to prevent moisture loss or limit moisture loss which provides an environment for the effective treatment of any wart where occlusive therapy may be practically administered. The occlusive article is formed of a flexible substrate material, such as occlusive tape with an adhesive for the purpose of attaching the article to the effected area.
A removable release liner covers the outer side of the adhesive portion of the occlusive article in order to afford protection thereto until desired use and to ease handling when administering.
The occlusive article is manufactured in various die-cut shapes, including but not limited to circular, square, rectangular, triangular, pentagonal, hexagonal, octagonal, trapezoidal, rhomboidal, hour glass, and elliptical in order to facilitate ease in consumer use and to accommodate consumer preferences.
The occlusive article is further provided in various flesh-colored tones via a color matching means in order to closely match and blend with a variety of skin pigments.
A kit is provided which contains an occluding or partially occluding means, such as a stack of individually-wrapped occlusive articles, synergistic therapies for wart resolution and instructions.
In an alternate embodiment briefly described according to the present invention, an occlusive article for wart treatment is disclosed, comprised of an occlusive component adapted to prevent moisture loss or limit moisture loss which provides an environment for the effective treatment of any wart where occlusive therapy may be practically administered. The occlusive article is formed of a flexible substrate material, such as occlusive tape with an adhesive for the purpose of attaching the article to the effected area.
The occlusive article is manufactured as a continuous roll in a continuous width including but not limited to 0.1 to 3.0 inches to facilitate ease in consumer use and to accommodate various wart sizes.
The occlusive article is further provided in various flesh-colored tones via a color matching means in order to closely match and blend with a variety of skin pigments.
A kit is provided which contains an occluding or partially occluding means, such as a roll of occlusive articles, synergistic therapies for wart resolution and instructions.
The advantages and features of the present invention will become better understood with reference to the following more detailed description and claims taken in conjunction with the accompanying drawings, in which like elements are identified with like symbols, and in which:
1. Detailed Description of the Figures
Referring now to
The occlusive article 20 is defined of a flexible material 30, for example occlusive or partially occlusive tape, film, sheet, or comparable backing. The occlusive article 20 is fabricated in a pre-cut shape and size to assist application and conformation to anatomical body parts and appendages that commonly harbor warts 70. Pre-cut shaped and sized occlusive articles 20 are provided on a readily peelable, single card or comparable backing as a plurality of occlusive article 20 units. As part of a final commercial product, the pre-cut shaped and sized occlusive articles 20 are packaged independently as a single card provided with a plurality of occlusive articles 20, or packaged with a plurality of cards, each card of the plurality of cards being provided with a plurality of occlusive articles 20. The pre-cut shaped and sized occlusive articles 20 are commercially available as an assortment of shapes and sizes in order to make selection of an appropriate shape and size optional to end user. Thus, the occlusive article 20 is manufactured in various die-cut shapes which include, but is not limited to circular, square, rectangular, triangular, pentagonal, hexagonal, octagonal, trapezoidal, rhomboidal, hour glass, and elliptical. The occlusive article 20 is manufactured utilizing suitable cutting die processing equipment (not shown) to facilitate ease in consumer use and to accommodate consumer preferences.
The occlusive article is further provided in various cosmetic tints and shades which mimic skin tones via a color matching means (not shown) in order to closely match and blend with a variety of skin pigments. A suitable color matching means known in the art is selected for coloring the occlusive articles 20 which minimizes visual detection of therapy by casual observers.
The occlusive article 20 further comprises an adhesive coating 32 disposed on an outer side of occlusive article 20 which functions as an occlusion or partial occlusion providing layer. The adhesive coating 32 contributes to occlusion through its inherent occlusive properties.
The occlusive article 20 is further defined of a single substrate 33 or multi-ply substrate 34 adapted to adhesively attach to an effected area. It is envisioned that the single substrate 33 or multi-ply substrate 34 is adapted with the adhesive coating 32 to facilitate adhesive attachment to an effected area.
A removable release liner 40 is included for embodiments incorporating an adhesive coating 32. The removable release liner 40 covers an outer side of the adhesive coating 32 in order to afford protection thereto until desired use. The removable release liner 40 is readily peelable from the adhesive coating 32. The removable release liner 40 aids in physical application of the occlusive article 20 and minimizes contamination of the adhesive coating 32 with inadvertent skin oil and debris contact. Occlusive article 20 embodiments incorporating the adhesive coating 32 and removable release liner 40 are fabricated in pre-cut shape and size and made available as individual units or in plurality using a die-cutting method. The individual units are packaged independently as a unit whether part of a final commercial package containing a plurality of units or sold individually.
Referring more specifically to FIG., the occlusive article 20 is shown provided as a continuous roll 50 of occlusive articles 20. The roll 50 includes a quantity of individual occlusive articles 20, each being easily severed from the roll 50. In order to facilitate effortless severance by each occlusive article 20 from the roll 50, a perforated severing line 52 is envisioned. The roll 50 of occlusive articles 20 defines a pre-cut width and a continuous length to promote easy dispensing of clinically relevant sized occlusive articles 20 for anatomical body parts and appendages that commonly harbor warts 70. The roll 50 of occlusive articles 20 has a slit width measuring approximately 0.10 inches to 3.0 inches.
The occlusive articles 20 of the roll 50 of occlusive articles 20 are each further defined as an occlusive or partially occlusive tape, film, sheet, or comparable backing. The occlusive articles 20 of the roll 50 of occlusive articles 20 are formed of a single substrate 33 or multi-ply substrate 34 adapted to adhesively attach to an effected area. It is envisioned that the single substrate 33 or multi-ply substrate 34 is adapted with an adhesive coating 32 to facilitate adhesive attachment to an effected area. The adhesive coating 32 contributes to occlusion through its inherent occlusive properties. A removable release liner 40 is also included for these embodiments incorporating the adhesive coating 32. The removable release liner 40 covers an outer side of the adhesive coating 32 and aids in the physical application of occlusive articles 20 and minimizes contamination of the adhesive coating 32 with inadvertent skin oil and debris contact.
The continuous roll 50 of occlusive articles 20 is further provided in various cosmetic tints and shades which mimic skin tones via a color matching means (not shown) in order to closely match and blend with a variety of skin pigments. A suitable color matching means known in the art is selected for coloring the roll 50 of occlusive articles 20 which minimizes visual detection of therapy by casual observers.
Referring now to FIG., a portable, lightweight dispenser 60 is provided for containing a continuous roll 50 of occlusive articles 20 in order to facilitate ease of retrieving or dispensing a single occlusive article 20 at a time. The dispenser 60 is adapted to house the continuous roll 50 of occlusive articles 20 in a suspended, rotational manner so as to allow individual occlusive articles 20 to be easily unrolled and dispensed therefrom. It is envisioned that the dispenser 60 is provided with a severing edge 65 to facilitate easy separation of a single occlusive article 20 from the roll 50 of occlusive articles 20 along the perforated severing line 52 thereof.
Referring now to FIGS., a multicomponent occlusive article 100 is provided. The multicomponent occlusive article 100 is comprised of an occlusive article 20 fabricated in a pre-cut shape and size affixed to a secondary adhesive tape 102 or comparable backing ultimately cut to a final size and shape. The multicomponent occlusive article 100 is adapted to augment occlusion and fixation of the occlusive article 20 thereof to anatomical body parts and appendages commonly harboring warts 70.
The occlusive article 20 of the multicomponent occlusive article 100 is defined of a flexible material, for example occlusive or partially occlusive tape, film, sheet, or comparable backing. The occlusive article 20 further comprises an adhesive coating 32 disposed on an outer side of occlusive article 20 to facilitate attachment of the occlusive article 20 to an effected area. The adhesive coating 32 contributes to occlusion through its inherent occlusive properties.
The occlusive article 20 of the muliticomponent occlusive article 100 is further defined of a single substrate 33 or a multi-ply substrate 34 adapted to adhesively attach to an effected area. It is envisioned that the single substrate 33 or multi-ply substrate 34 is adapted with the adhesive coating 32 to facilitate adhesive attachment to an effected area. The pre-cut shaped and sized occlusive articles 20 and secondary adhesive tape 102 or comparable backing include a removable release liner, wherein pre-cut shaped and sized occlusive articles 20 and secondary adhesive tape 102 incorporating the removable release liner 40 are made available as individual units using a die-cutting method or in plurality to aid in physical application of the multicomponent occlusive article 100 and to minimize contamination of adhesive coating 32 with inadvertent skin oil and debris contact. The individual units are packaged independently as a unit whether part of a final commercial package or sold individually.
The multicomponent occlusive article 100 is also provided on a readily peelable, single card or comparable backing as a plurality of occlusive article 20 units. As part of a final commercial product, the multicomponent occlusive article 100 is packaged independently as a single card provided with a plurality of occlusive articles 20, or packaged with a plurality of cards, each card of the plurality of cards being provided with a plurality of occlusive articles 20.
The pre-cut shaped and sized occlusive articles 20 of the multicomponent occlusive article 100 are commercially available as an assortment of shapes and sizes in order to make selection of an appropriate shape and size optional to end user.
The pre-cut shaped and sized occlusive articles and the secondary adhesive tape 102 or comparable backing of the multicomponent occlusive article 100 are available in various cosmetic tints and shades which mimic skin tones and minimize visual detection of therapy by casual observers.
Referring now to FIG., a kit 80 is provided for treating a wart 70 which comprises a package 82 for housing an occluding or partially occluding means, wherein occluding or partially occluding means is an occlusive article(s) 20. The kit 80 further comprises a continuous roll 50 of occlusive articles 20 and a multicomponent occlusive article 100. Synergistic therapies may also be provided as kit components which include but are not limited to anthralin, salicylic acid, lactic acid, glacial acetic acid, nitric acid, trichloracetic acid, and bichloroacetic acid. An instruction leaflet 76 is also provide in the kit 80.
Further in accordance with the present invention, a method is provided for treating one or more warts 70, wherein the method comprises the steps of removing the dispenser 60 from the package 82, severing at least one occlusive article 20 from the roll 50 of occlusive articles 20 using the severing edge 65 of dispenser 60, removing the release liner 40 from occlusive article 20, covering the wart 70 and skin area peripheral to the wart 70 with the outer side of occlusive article 20 lying in contact against the wart 70 so as to provide an occlusive or partially occlusive environment therefore maintaining the occlusive article 20 in position over wart 70 and skin area peripheral thereto for a predetermined period of time, removing the occlusive article 20 after the predetermined period of time, and repeating the aforementioned steps until a desired level of wart 70 removal has been acquired. The aforementioned method for treating one or more warts 70 may further include the step of debriding the wart 70 after removing the occlusive article 20 after the predetermined period of time, and then repeating the steps stated hereinabove.
2. Operation of the Preferred Embodiment
To use the present invention, user removes the occlusive article dispenser 60 from the package 82, severs at least one occlusive article 20 from the roll 50 of occlusive articles 20 using the severing edge 65 of dispenser 60, removes the release liner 40 from occlusive article 20, covers the wart 70 and skin area peripheral to the wart 70 with the outer side of occlusive article 20 lying in contact against the wart 70 so as to provide an occlusive or partially occlusive environment therefore. User then maintains the occlusive article 20 in position over wart 70 and skin area peripheral thereto for a predetermined period of time. User next removes the occlusive article 20 after the predetermined period of time, and repeats the aforementioned procedure until a desired level of wart 70 removal has been acquired.
The use of the present invention provides not only a less painful and invasive therapy for wart removal, but also a more cosmetically acceptable solution.
Therefore, the foregoing description is included to illustrate the operation of the preferred embodiment and is not meant to limit the scope of the invention. As one can envision, an individual skilled in the relevant art, in conjunction with the present teachings, would be capable of incorporating many minor modifications that are anticipated within this disclosure. The foregoing descriptions of specific embodiments of the present invention have been presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed, and obviously many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the Claims appended hereto and their equivalents. Therefore, the scope of the invention is to be broadly limited only by the following Claims.
